E-Learning

(Bloomberg) -- A rotation into defensive shares coupled with supportive government policies is boosting the appeal of underperforming Chinese health-care stocks.Most Read from BloombergManchester Is Giving London a Run for Its MoneyBoston’s Broke and Broken Transit System Hurts Downtown RecoveryA Warehouse Store Promises Housing for South LA, in BulkBiden Invests $100 Million to Fuel Housing ConstructionJohannesburg Mayor Quits Amid Infighting, Financial WoesSigns of improving sentiment are emer

Big investors are bracing for this summer's stock market rout to run into the autumn, fearing a broader wave of selling will follow the turmoil sparked by US recession concerns and the Bank of Japan wrong-footing currency speculators. The sudden reversal of crowded equity and foreign exchange trades that generated vicious feedback loops of price drops, volatility and hedge fund selling has eased, with world stocks almost 2% higher so far this week. But asset managers overseeing hundreds of billions of dollars of investments said they were more likely to carry on selling stocks than buy back in, with signs of weakness in the U.S. jobs market and global consumer trends lowering the bar for market aftershocks.

(Bloomberg) -- Shares of Danish vaccine developer Bavarian Nordic A/S jumped, while other medical product makers also rose, after the World Health Organization declared a fast-spreading mpox outbreak in Africa a global health emergency.Most Read from BloombergManchester Is Giving London a Run for Its MoneyBoston’s Broke and Broken Transit System Hurts Downtown RecoveryA Warehouse Store Promises Housing for South LA, in BulkBiden Invests $100 Million to Fuel Housing ConstructionJohannesburg Mayor

(Bloomberg) -- Equities in Japan and China advanced, following gains on Wall Street, as investors cheered a string of encouraging economic data points from the world’s three largest economies.Most Read from BloombergManchester Is Giving London a Run for Its MoneyBoston’s Broke and Broken Transit System Hurts Downtown RecoveryA Warehouse Store Promises Housing for South LA, in BulkBiden Invests $100 Million to Fuel Housing ConstructionJohannesburg Mayor Quits Amid Infighting, Financial WoesJapan’

Asian shares were mostly higher Thursday after the latest update on U.S. inflation came in almost exactly as economists expected, and data on Japan’s economy showed relatively healthy growth. Japan’s benchmark Nikkei 225 added 0.8% to finish at 36,726.64. Hong Kong’s Hang Seng declined 0.3% to 17,054.92, while the Shanghai Composite surged 1.0% to 2,877.73.

TOKYO (Reuters) -Asian stocks were firm on Thursday while the dollar remained on the back foot amid lower U.S. Treasury yields after benign consumer inflation data overnight reinforced bets for the Federal Reserve to start cutting interest rates next month. U.S. S&P 500 futures pointed 0.16% higher after the cash index advanced 0.4% on Wednesday, buoyed by the slowest rise in the consumer price index in more than three years. "The report 'checked the box' for the Fed to start cutting rates in September," TD Securities analysts wrote in a report.

(Bloomberg) -- Iron ore hit the lowest level since 2022 on concern that global supply is running ahead of demand, with China’s steelmakers mired in a crisis and cutting output just as major miners boost exports.Most Read from BloombergManchester Is Giving London a Run for Its MoneyBoston’s Broke and Broken Transit System Hurts Downtown RecoveryA Warehouse Store Promises Housing for South LA, in BulkBiden Invests $100 Million to Fuel Housing ConstructionJohannesburg Mayor Quits Amid Infighting, F

Last week’s spate of market volatility, the poor July jobs report, and the prospect of Federal Reserve interest rate cuts are together prompting renewed fears of a near-term recession. A recent contraction in the PMI – purchasing managers’ index – hasn’t helped matters. And while the market is bouncing back this week, investors are starting to diversify their portfolios – and are looking for a slightly more defensive stance. The packaged food industry makes a sound place to look for such portfol

The GLP-1 (weight-loss drug) boom is continuing to gain steam. As the two leaders in the space, Eli Lilly (LLY) and Novo Nordisk (NVO) stand out as top picks for investors to play the trend. Though the two biotech innovators have felt the pressure from the July-August market sell-off, high demand and efforts to ramp up production seem to be setting the stage for a glorious growth surge at some point over the near future. As always, though, one firm may be in better shape than the other to seize